文献速递眼底病与葡萄膜炎

低亮度视觉缺陷如何随糖尿病性黄斑缺血和糖尿病视网膜病变进展而演变

Understanding How Low Luminance Visual Deficit Progresses With Advancing Diabetic Macular Ischemia and Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究评估低亮度缺陷(LLD)与糖尿病性黄斑缺血在光学相干断层扫描血管成像(OCTA)上的相关性。纳入91只非转诊DR眼、94只转诊DR眼和76只静止期激光治疗PDR眼,均无黄斑水肿。结果显示BCVA和LLVA随DR严重程度下降,LLD在不同DR阶段呈现不同模式:转诊DR中LLD较大源于LLVA下降,静止期PDR中LLD较小反映BCVA下降更明显。

要点

  • BCVA和LLVA均随DR严重程度增加而下降(P < 0.001)。
  • 转诊DR的LLD(9.8 ± 4.4)高于非转诊DR(8.1 ± 3.12)和静止期PDR(7.3 ± 3.52)(P < 0.001)。
  • LLD与深层毛细血管丛血管长度密度在全队列中呈负相关(β = -3.01;P = 0.030)。

核心结论

  • BCVA和LLVA均随DR进展而下降,但LLD在不同DR阶段呈现不同模式。
  • 转诊DR中LLD较大源于LLVA下降,静止期PDR中LLD较小反映BCVA下降更明显。
  • LLD可能作为监测糖尿病眼黄斑缺血进展的简单实用工具。

研究设计与样本

  • 研究纳入91只非转诊DR眼(无/轻度DR)、94只转诊DR眼(中度/重度非增殖性DR、未治疗增殖性DR)和76只静止期激光治疗PDR眼,均无黄斑水肿。
  • 使用ETDRS视力表评估最佳矫正视力(BCVA)和低亮度视力(LLVA;使用2.0 log单位中性密度滤光片),记录为ETDRS字母评分,LLD计算为BCVA - LLVA。
  • 从OCTA 3×3 mm扫描中量化深层(DCP)和浅层(SCP)毛细血管丛的几何灌注缺陷(GPD)、血管长度密度(VLD)和血管密度(VD)。
  • 采用线性回归分析LLD与OCTA指标之间的关联。

主要发现

  • BCVA在三组中分别为86.6 ± 5.02、83.5 ± 5.95、76.8 ± 9.52(P < 0.001),随DR严重程度下降。
  • LLVA在三组中分别为78.5 ± 5.18、73.8 ± 7.84、69.5 ± 9.61(P < 0.001),随DR严重程度下降。
  • LLD在转诊DR中为9.8 ± 4.4,高于非转诊DR的8.1 ± 3.12和静止期PDR的7.3 ± 3.52(P < 0.001)。
  • LLD与DCP VLD在全队列(转诊和非转诊DR)中呈负相关(β = -3.01;P = 0.030)。
  • LLD与DCP GPD在静止期PDR眼中呈负相关(β = -1.77;P = 0.032)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess whether low luminance deficit (LLD) correlates with diabetic macular ischemia on optical coherence tomography angiography (OCTA). METHODS: Best-corrected visual acuity (BCVA) and low luminance visual acuity (LLVA; using 2.0-log unit neutral density filter) were assessed with Early Treatment Diabetic Retinopathy Study (ETDRS) charts and recorded as ETDRS letter scores. Low-luminance deficit (LLD) was calculated as BCVA - LLVA. From OCTA 3 × 3 mm scans, geometric perfusion deficits (GPD), vessel length density (VLD), and vessel density (VD) in deep (DCP) and superficial (SCP) capillary plexuses were quantified. Linear regression analyzed associations between LLD and OCTA metrics. RESULTS: The study included 91 non-referable (no/mild DR), 94 referable (moderate/severe nonproliferative DR, treatment naïve PDR), and 76 quiescent laser-treated PDR eyes, all without macular edema. BCVA (86.6 ± 5.02, 83.5 ± 5.95, 76.8 ± 9.52; P < 0.001) and LLVA (78.5 ± 5.18, 73.8 ± 7.84, 69.5 ± 9.61; P < 0.001) declined with increasing DR severity. LLD was higher in referable DR (9.8 ± 4.4) versus non-referable DR (8.1 ± 3.12) and quiescent PDR eyes (7.3 ± 3.52; P < 0.001). LLD was negatively associated with DCP VLD in the entire cohort (referable and non-referable DR; β = -3.01; P = 0.030) and with DCP GPD in quiescent PDR eyes (β = -1.77; P = 0.032). CONCLUSIONS: Both BCVA and LLVA decline with DR progression; however, distinct LLD patterns have emerged across DR stages. In referable DR, LLD is larger as a result of LLVA decline, whereas in quiescent PDR smaller LLD reflects a greater decline in BCVA. These findings emphasize the nuanced relationship of LLD with photopic and mesopic visual functions, which decline in distinct patterns across DR stages. LLD may serve as a simple and practical tool for monitoring macular ischemia progression in diabetic eyes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Shah J, Zhuang K, Kakihara S, et al. Understanding How Low Luminance Visual Deficit Progresses With Advancing Diabetic Macular Ischemia and Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2025. PMID: 41134256. doi:10.1167/iovs.66.13.38

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。